Back to Authors

Zuniga, Leslie A.

Mayo Clinic

Mayo Clinic

Citations 4

NMDA-receptor Autoimmunity and Opsoclonus-Myoclonus Syndrome Occurring with Rituximab Treatment of Autoimmune Autonomic Neuropathy (P5.304)
Dumitrașcu, Oana , Zuniga, Leslie A., Grill, Marie , Goodman, Brent P., McKeon, Andrew

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p5.304 Get It

Rheumatoid Meningitis
Parsons, Angela, Zuniga, Leslie A., Lyons, Mark , Aslam, Fawad , Goodman, Brent P., Aslam, Fawad , Zuniga, Leslie A., Hoxworth, Joseph M.

The Neurologist | May 4, 2018 | Volume: 23 | Issue: 3 | Pages: 83-85

10.1097/nrl.0000000000000158 Get It

Introduction: Rheumatoid meningitis (RM) is a rare complication of rheumatoid arthritis (RA) and has a high mortality rate. It can present as a first diagnosis of RA, in long-standing disease, or in active or well-controlled disease. Neurological manifestations vary widely. Case Report: A patient with a 30-year history of RA, well controlled with methotrexate therapy, presented with new-onset seizures. Magnetic resonance imaging showed leptomeningeal and pachymeningeal enhancement. A de novo workup resulted in diagnosis of RM. Conclusions: Cerebrospinal fluid findings for RM are nonspecific, typically lymphocytic pleocytosis; however, they can be neutrophilic, as in this case. Magnetic resonance imaging findings consist of leptomeningeal and pachymeningeal enhancement but can also involve the parenchyma. The diagnosis is typically confirmed with meningeal biopsy. Treatment involves high-dose corticosteroids or immunomodulatory therapy, or both. Long-term follow-up with radiologic surveillance typically ranges from improvement to resolution.
Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
Dumitrașcu, Oana , McKeon, Andrew , Zuniga, Leslie A., Grill, Marie , Goodman, Brent P., Zuniga, Leslie, Grill, Marie F, McKeon, Andrew

Neurology Neuroimmunology & Neuroinflammation | June 29, 2017 | Volume: 4 | Issue: 5 | Pages: No page available

10.1212/nxi.0000000000000376 Get It

Low heat pain thresholds in migraineurs between attacks
Zuniga, Leslie A., Chong, Catherine D. , Schwedt, Todd J. , Zuniga, Leslie, Chong, Catherine D

Cephalalgia | September 23, 2014 | Volume: 35 | Issue: 7 | Pages: 593-599

10.1177/0333102414550417 Get It

Background/Objective Between attacks, migraine is associated with hypersensitivities to sensory stimuli. The objective of this study was to investigate hypersensitivity to pain in migraineurs between attacks. Methods Cutaneous heat pain thresholds were measured in 112 migraineurs, migraine free for ≥48 hours, and 75 healthy controls. Pain thresholds at the head and at the arm were compared between migraineurs and controls using two-tailed t-tests. Among migraineurs, correlations between heat pain thresholds and headache frequency, allodynia symptom severity, and time interval until next headache were calculated. Results Migraineurs had lower pain thresholds than controls at the head (43.9℃ ± 3.2℃ vs. 45.1℃ ± 3.0℃, p = 0.015) and arm (43.2℃ ± 3.4℃ vs. 44.8℃ ± 3.3℃, p < 0.001). There were not significant correlations between pain thresholds and headache frequency or allodynia symptom severity. For the 41 migraineurs for whom time to next headache was known, there were positive correlations between time to next headache and pain thresholds at the head ( r = 0.352, p = 0.024) and arm ( r = 0.312, p = 0.047). Conclusions This study provides evidence that migraineurs have low heat pain thresholds between migraine attacks. Mechanisms underlying these lower pain thresholds could also predispose migraineurs to their next migraine attack, a hypothesis supported by finding positive correlations between pain thresholds and time to next migraine attack.